pharma services Oehler GmbH
- Sector unverified
- Rank 261 / 334
pharma services Oehler GmbH is recorded by Swissmedic as the authorisation holder for 2 human medicines, which places it 261 of 334 authorisation holders. Its portfolio is mostly in the Synthetika category (100 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 2 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
pharma services Oehler GmbH is recorded by Swissmedic as the authorisation holder for 2 human medicines. The table shows 2 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
2 of 2 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Anapen 300 Mikrogramm | 57570 | B | - | 2007-05-25 |
| Aqumeldi 0.25 mg | 70307 | B | C09AA02 | 2025-12-11 |
Frequently asked questions
How many medicines does pharma services Oehler GmbH have authorised in Switzerland?
pharma services Oehler GmbH is recorded by Swissmedic as the authorisation holder for 2 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is pharma services Oehler GmbH based?
We have no confirmed Swiss address for pharma services Oehler GmbH. We add it as soon as the commercial register or the company confirms it.
Is pharma services Oehler GmbH a Swissmedic authorisation holder?
Yes. pharma services Oehler GmbH appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.